A Johnson & Johnson building is shown in Irvine, California.

Mike Blake | Reuters

Johnson & Johnson announced Wednesday that it will develop and deliver 100 million doses of its coronavirus vaccine for the U.S. in a deal totaling more than $1 billion. 

The deal gives the U.S. the option to order an additional 200 million doses, the company said. 

“We are scaling up production in the U.S. and worldwide to deliver a SARS-CoV-2 vaccine for emergency use,” said Paul Stoffels, chief science officer at Johnson & Johnson, in a statement. 

This is developing news. Please check back later for updates.